Global Vaccine Adjuvants Market - Growth Opportunities, Competitive Insights, and Forecast to 2030

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

How Does the Projected Market Size of the Vaccine Adjuvants Market Compare to 2026 Levels?
The vaccine adjuvants market size has grown strongly in recent years. It will grow from $2.01 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growing prevalence of infectious diseases, increasing government funding for vaccine research, rising adoption of traditional vaccines, development of oil-in-water and water-in-oil emulsions, technological advancements in pathogen component adjuvants.

The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising demand for human and veterinary vaccines, increasing focus on cancer and infectious disease immunotherapies, innovations in nanoparticle and liposome adjuvants, regulatory support for novel adjuvants, expansion of biologics manufacturing infrastructure. Major trends in the forecast period include personalized vaccine adjuvant development, novel immunostimulatory compounds, multi-disease targeted adjuvants, enhanced safety and efficacy profiles, rapid vaccine formulation platforms.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Who Are the Major Contributors to the Vaccine Adjuvants Market Growth?
The growing funding for vaccine research activities is expected to propel the growth of the vaccine adjuvants market going forward. Vaccine research activities can be defined as comprehensive scientific endeavors aimed at developing, testing, and improving vaccines to prevent infectious diseases. Research activities play a vital role in developing, testing, and optimizing potential adjuvant candidates from various sources, including natural products, synthetic compounds, and even bacteria or viruses. For instance, in October 2023, the United States Department of Health and Human Services, a US-based provider of essential human services, announced Project NextGen with a $500 million investment to begin developing phase 2b clinical trial plans and technologies that develop cutting-edge next-generation vaccination and treatment platforms. Therefore, the growing funding for vaccine research activities is driving the growth of the vaccine adjuvants market.

What Are the Key Segment Classifications in the Vaccine Adjuvants Market?
The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:
1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions
2) By Pathogen Components: Bacterial Components, Viral Components
3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles
4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems
5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

What Are the Emerging Market Trends That Companies Should Monitor in Vaccine Adjuvants Market?
Major companies operating in the vaccine adjuvants market are focusing on technological advancements, such as cultured-plant-cell QS-21 (cpcQS-21), to meet the rising demand for more sustainable and scalable production of potent immune-stimulatory adjuvants. QS-21 is a potent saponin adjuvant traditionally extracted from the bark of Quillaja saponaria trees; unlike conventional aluminum-based adjuvants, QS-21 elicits both strong antibody and cellular immune responses, but its supply is limited by the scarcity of tree bark and variability in quality. In August 2024, SaponiQx, a US-based biomanufacturing company, launched STIMULON cultured plant cell QS-21, a cpcQS-21 adjuvant available for commercial purchase through InvivoGen. This product is produced via plant cell culture rather than tree bark, ensuring consistent and scalable supply; it offers high purity, lot-to-lot uniformity, and reduced environmental impact. Functionally, STIMULON cpcQS-21 retains the same immunostimulatory potency as tree-derived QS-21 in driving both humoral and cellular immune responses, making it suitable for use in vaccines for infectious diseases such as malaria, shingles, and RSV.

Which Organizations Are Key Contributors to the Vaccine Adjuvants Market?
Major companies operating in the vaccine adjuvants market are GlaxoSmithKline Plc., Novavax Inc., Agenus Inc., CSL Limited, Adjuvatis, Merck KGaA, Seppic Inc., Virometix AG, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc.

Get the full vaccine adjuvants market report here:
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which regions are expected to experience the fastest growth in the Vaccine Adjuvants Market?
North America was the largest region in the vaccine adjuvants market in http://2025.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn